Trademark: 90508314
Status Date
Monday, June 24, 2024
Filing Date
Wednesday, February 3, 2021
Published for Opposition
Tuesday, September 28, 2021
Abandoned Date
Monday, June 24, 2024
5 Biologics for medical use, namely, biological preparations for the treatment or prophylaxis of cancer; biologics for medical use, namely, biological preparations for the treatment or prophylaxis of infectious diseases; pharmaceutical preparations, biologics and antibodies for the treatment of oncological, infectious disease, and immune system related diseases, disorders and conditions; diagnostic agents, preparations and substances for medical purposes; diagnostic kits consisting primarily of monoclonal antibodies, buffers, and reagents for use in disease testing; diagnostic preparations, biologics and antibodies for medical purposes, namely, for detecting the presence of malignant, inflammatory, infectious and autoimmune diseases, disorders and conditions in humans
1 Diagnostic preparations for clinical use and scientific research; biological tissue cultures for clinical use and scientific research; antibodies for clinical use and scientific research; combinations of biological tissue cultures for clinical use and scientific research; and combinations of antibodies for clinical use and scientific research
42 Biological and pharmaceutical research and development; research, design and development of diagnostics for predicting the response of patients to therapeutics; research, design and development of biologics; research, design and development of combinations of such diagnostics and biologics; molecular biology research for diagnostic preparations, biologics, combinations of diagnostic preparations and biologics, and diagnostic kits for scientific research use; scientific research in the field of cancer and infectious disease treatment and diagnosis; providing laboratory research services in the field of cancer biology and infectious disease biology; testing, inspection, research and development of pharmaceutical preparations for cancer and infectious diseases; providing laboratory research services in the field of cancer biology and infectious diseases; research and development services in the field of antibodies; providing medical and scientific research information in the fields of cancer research, infectious disease research and disease classification; providing medical and scientific research information in the field of pharmaceuticals and clinical trials
The mark consists of a geometric design composed of three arrows pointing inward on a background that forms its own multi-sided geometric design with three distinct sections, each corresponding to one of the arrows, and three arrowheads pointing inwards. The black in the drawing is intended to show background and shading.
Feb 6, 2021
New Application Entered
May 6, 2021
New Application Office Supplied Data Entered
May 7, 2021
Notice Of Design Search Code E-Mailed
Aug 24, 2021
Assigned To Examiner
Aug 25, 2021
Approved For Pub - Principal Register
Aug 27, 2021
Teas Change Of Owner Address Received
Aug 27, 2021
Teas Change Of Correspondence Received
Aug 27, 2021
Applicant/Correspondence Changes (Non-Responsive) Entered
Sep 8, 2021
Notification Of Notice Of Publication E-Mailed
Sep 28, 2021
Published For Opposition
Sep 28, 2021
Official Gazette Publication Confirmation E-Mailed
Nov 23, 2021
Noa E-Mailed - Sou Required From Applicant
May 11, 2022
Sou Teas Extension Received
May 11, 2022
Sou Extension 1 Filed
May 11, 2022
Sou Extension 1 Granted
May 13, 2022
Notice Of Approval Of Extension Request E-Mailed
Oct 3, 2022
Sou Teas Extension Received
Oct 3, 2022
Sou Extension 2 Filed
Oct 3, 2022
Sou Extension 2 Granted
Oct 5, 2022
Notice Of Approval Of Extension Request E-Mailed
May 3, 2023
Sou Teas Extension Received
May 3, 2023
Sou Extension 3 Filed
May 3, 2023
Sou Extension 3 Granted
May 5, 2023
Notice Of Approval Of Extension Request E-Mailed
Oct 5, 2023
Sou Teas Extension Received
Oct 5, 2023
Sou Extension 4 Filed
Oct 5, 2023
Sou Extension 4 Granted
Oct 7, 2023
Notice Of Approval Of Extension Request E-Mailed
Jun 24, 2024
Abandonment - No Use Statement Filed
Trademark Alertz updated from USPTO on 2030-01-24
